Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending February 28, 2023 was $2.49 Million (a 222.5% increase compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense decreased by -66.59%
- Annual Non-operating Income/Expense for 2022 was $22.6 Million (a -173.78% decrease from previous year)
- Annual Non-operating Income/Expense for 2021 was $-30.7 Million (a 3587.36% increase from previous year)
- Annual Non-operating Income/Expense for 2020 was $-832 Thousand (a -90.3% decrease from previous year)
- Twelve month Non-operating Income/Expense ending February 28, 2023 was $12.2 Million (a -9.57% decrease compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense decreased by -30.84% year-over-year
Trailing Non-operating Income/Expense for the last four month:
28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
---|---|---|---|
$12.2 Million | $13.5 Million | $22.6 Million | $17.7 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Organigram Holdings Inc.
Most recent Non-operating Income/Expenseof OGI including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Organigram Holdings Inc.
Organigram Holdings Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $2.49 | – | – | – | – |
2022 | $0.77 | $1.52 | $7.44 | $3.78 | $22.63 |
2021 | $9.89 | $-3.44 | $6.55 | $-29.12 | $-30.67 |
2020 | $-4.65 | $2.83 | $-0.38 | $-2.66 | $-0.83 |
2019 | $-0.62 | $-0.77 | $-0.85 | $-3.93 | $-8.57 |
2018 | – | – | – | $-3.01 | $-6.77 |
2017 | – | – | – | – | $1.08 |
2016 | – | – | – | – | $-0.22 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic